Data as of Apr 17
| +0.02 / +1.27%|
The 1 analysts offering 12-month price forecasts for InVivo Therapeutics Holdings Corp have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +150.00% increase from the last price of 1.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.